These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28126926)

  • 21. Transient myelodysplastic syndrome associated with isochromosome 7q abnormality.
    Leung EW; Woodman RC; Roland B; Abdelhaleem M; Freedman MH; Dror Y
    Pediatr Hematol Oncol; 2003; 20(7):539-45. PubMed ID: 12959859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current diagnosis and treatment for myelodysplastc syndromes].
    Hata T
    Rinsho Ketsueki; 2017; 58(4):373-380. PubMed ID: 28484169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment.
    Yi JH; Huh J; Kim HJ; Kim SH; Kim SH; Kim KH; Do YR; Mun YC; Kim H; Kim MK; Kim HJ; Kim T; Kim DD
    Ann Hematol; 2013 Apr; 92(4):459-69. PubMed ID: 23262795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias.
    Vercauteren SM; Bashashati A; Wu D; Brinkman RR; Eaves C; Eaves A; Karsan A
    Leuk Res; 2009 Dec; 33(12):1636-42. PubMed ID: 19414193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q.
    Nimer SD
    J Clin Oncol; 2006 Jun; 24(16):2576-82. PubMed ID: 16735711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using peripheral blood circulating DNAs to detect CpG global methylation status and genetic mutations in patients with myelodysplastic syndrome.
    Iriyama C; Tomita A; Hoshino H; Adachi-Shirahata M; Furukawa-Hibi Y; Yamada K; Kiyoi H; Naoe T
    Biochem Biophys Res Commun; 2012 Mar; 419(4):662-9. PubMed ID: 22382018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDS prognostic scoring systems – past, present, and future.
    Jonas BA; Greenberg PL
    Best Pract Res Clin Haematol; 2015 Mar; 28(1):3-13. PubMed ID: 25659725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
    Jhanwar SC
    Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis].
    Mishima M; Makita M; Sando Y; Yamamoto Y; Shiote Y; Hara Y; Yamamoto K; Imajo K
    Rinsho Ketsueki; 2015 Jan; 56(1):35-7. PubMed ID: 25745966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation and hematopoietic-support of clonal cells in myelodysplastic syndromes.
    Li X; Wu L; Ying S; Chang C; He Q; Pu Q
    Leuk Lymphoma; 2007 Jul; 48(7):1353-71. PubMed ID: 17613765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonality of the stem cell compartment during evolution of myelodysplastic syndromes and other bone marrow failure syndromes.
    Tiu R; Gondek L; O'Keefe C; Maciejewski JP
    Leukemia; 2007 Aug; 21(8):1648-57. PubMed ID: 17554386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
    Lee YG; Kim I; Yoon SS; Park S; Cheong JW; Min YH; Lee JO; Bang SM; Yi HG; Kim CS; Park Y; Kim BS; Mun YC; Seong CM; Park J; Lee JH; Kim SY; Lee HG; Kim YK; Kim HJ;
    Br J Haematol; 2013 May; 161(3):339-47. PubMed ID: 23432512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
    Aul C; Giagounidis A; Germing U; Ganser A
    Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome.
    Mohamedali AM; Alkhatabi H; Kulasekararaj A; Shinde S; Mian S; Malik F; Smith AE; Gäken J; Mufti GJ
    Blood; 2013 Jul; 122(4):567-70. PubMed ID: 23760614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of MDS: morphology, chromosome abnormalities and genetic mutations].
    Hata T
    Rinsho Ketsueki; 2015 Oct; 56(10):1978-84. PubMed ID: 26458436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances of study on immunophenotyping of myelodysplastic syndromes-review].
    Qiao C; Fan L; Wu YJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):1106-10. PubMed ID: 19698271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis in serial marrow samples during azacitidine treatment in patients with post-transplant relapse of acute myeloid leukemia or myelodysplastic syndromes.
    Woo J; Howard NP; Storer BE; Fang M; Yeung CC; Scott BL; Deeg HJ
    Haematologica; 2017 Jun; 102(6):e216-e218. PubMed ID: 28209655
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytogenetic and molecular abnormalities in myelodysplastic syndrome.
    Nagoshi H; Horiike S; Kuroda J; Taniwaki M
    Curr Mol Med; 2011 Nov; 11(8):678-85. PubMed ID: 21902648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.